Cumberland Pharmaceuticals
Manufacturing · Tennessee, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
2525 W End Ave Ste 950, Nashville, Tenne...Phone Number
(877) 274-7200Website
www.vaprisol.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Cumberland Pharmaceuticals
Cumberland Pharmaceuticals is a specialty pharmaceutical company that manufactures and markets Vaprisol, an intravenous treatment for hyponatremia used in critical care settings. Hyponatremia is a medical condition characterized by abnormally low sodium concentration in blood plasma, which can occur with various critical illnesses including heart failure, liver failure, kidney failure, and pneumonia. Vaprisol functions as a vasopressin receptor antagonist that elevates serum sodium levels and facilitates free water secretion. The product received FDA approval for euvolemic hyponatremia in 2005 and for hypervolemic hyponatremia in 2007. Cumberland Pharmaceuticals operates in North America and offers mobile application solutions to support their pharmaceutical products.Explore more
Popular SearchesCumberland Pharmaceuticals IncVaprisolSIC Code 28,283NAICS Code 32,325Show moreSell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Cumberland Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Cumberland Pharmaceuticals had a recent Job posting/layoffs
Check out if Cumberland Pharmaceuticals is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Cumberland Pharmaceuticals
Funding: Get notified immidiatlly once Cumberland Pharmaceuticals has new funding data
Earning: See what the market has to say on Cumberland Pharmaceuticals recently announced quarterly report
Cumberland Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Check if Cumberland Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Cumberland Pharmaceuticals launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Find VP level buyers at Cumberland Pharmaceuticals
Find more new buyers
Compare Similar Companies to Cumberland Pharmaceuticals
Compare insights from companies similar to Cumberland Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Cumberland Pharmaceutical...
<$5M
11-50
Private
-
-
N/A
Company Profile Activity
Activity Insights
Cumberland Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Cumberland Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Cumberland Pharmaceuticals.
Cumberland Pharmaceuticals Tech Stack
A closer look at the technologies used by Cumberland Pharmaceuticals
Cumberland Pharmaceuticals News & Media
Read more news
Top Manufacturing Companies
See more top companies
Frequently Asked Questions Regarding Cumberland Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Cumberland Pharmaceuticals is a specialty pharmaceutical company that manufactures and markets Vaprisol, an intravenous treatment for hyponatremia used in critical care settings. Hyponatremia is a medical condition characterized by abnormally low sodium concentration in blood plasma, which can occur with various critical illnesses including heart f... Read More
